Search papers, labs, and topics across Lattice.
1
0
0
2
The high efficacy and safety profile of the pangenotypic DAA regimens GLE/PIB and VEL/SOF for the treatment of chronic hepatitis C in children 3 years of age and older has been proven using communication technologies and substantiates the possibility of a simplified regimen for the management of children with HCV.